Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research, Cambridge, USA.
Eur J Pharm Sci. 2010 Sep 11;41(1):23-30. doi: 10.1016/j.ejps.2010.05.009. Epub 2010 May 27.
Salt screening and selection is a well established approach for improving the properties of drug candidates, including dissolution rate and bioavailability. Typically during early development only small amounts of compound are available for solid state profiling, including salt screening. In order to probe large areas of experimental space, high-throughput screening is utilized and is often designed in a way to search for suitable crystallization parameters within hundreds or even thousands of conditions. However, the hit rate in these types of screens can be very low. In order to allow for selection of a salt form early within the drug development process whilst using smaller amounts of compounds, a screening procedure taking into account the compounds properties and the driving forces for salt formation is described. Experiments were carried out on the model compounds clotrimazole, cinnarizine itraconazole and atropine. We found an increase in crystalline hit rate for water-insoluble drugs crystallized from solutions that included at least 10% aqueous content. Conversely it was observed that compounds with greater water solubility did not benefit from aqueous content in salt screening, instead organic solvents lead to more crystalline screening hits. Results from four model compounds show that the inclusion of an aqueous component to the salt reaction can enhance the chance of salt formation and significantly improve the crystalline hit rate for low water soluble drugs.
盐筛选和选择是一种成熟的方法,可以改善候选药物的性质,包括溶解速率和生物利用度。通常在早期开发阶段,只有少量的化合物可用于固体状态分析,包括盐筛选。为了探测大量的实验空间,通常会利用高通量筛选,并且设计方式通常是在数百甚至数千种条件下寻找合适的结晶参数。然而,这些类型的筛选中的命中率可能非常低。为了在药物开发过程中尽早选择盐形式,同时使用较少的化合物,描述了一种考虑化合物性质和盐形成驱动力的筛选程序。实验是在模型化合物克霉唑、肉桂嗪、伊曲康唑和阿托品上进行的。我们发现,从包含至少 10%水含量的溶液中结晶的水不溶性药物的结晶命中率有所提高。相反,我们观察到具有更高水溶性的化合物从盐筛选中的水含量中没有受益,相反有机溶剂导致更多的结晶筛选命中。来自四个模型化合物的结果表明,将水相成分纳入盐反应中可以提高盐形成的机会,并显著提高低水溶性药物的结晶命中率。